Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Looking Closely at the Growth Curve for Cigna Corporation (CI)

researchsnappy by researchsnappy
December 3, 2020
in Investment Research
0
The Chart for Shift4 Payments Inc. (FOUR) Is Flashing Mixed Signals
400
SHARES
2.4k
VIEWS
Share on FacebookShare on Twitter


Cigna Corporation (NYSE:CI) went up by 2.17% from its latest closing price compared to the recent 1-year high of $224.96. The company’s stock price has collected 0.95% of gains in the last five trading sessions. MarketWatch.com reported 5 hours ago that Cigna Corp. stock outperforms market on strong trading day

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in Cigna Corporation (NYSE :CI) Right Now?

Cigna Corporation (NYSE:CI) scored a price-to-earnings ratio above its average ratio, recording 14.86 x from its present earnings ratio. Plus, the 36-month beta value for CI is at 0.85. Opinions of the stock are interesting as 22 analysts out of 27 who provided ratings for Cigna Corporation declared the stock was a “buy,” while 2 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”

The average price from analysts is $254.76, which is $40.26 above the current price. CI currently public float of 355.81M and currently shorts hold a 1.04% ratio of that float. Today, the average trading volume of CI was 2.07M shares.

CI’s Market Performance

CI stocks went up by 0.95% for the week, with a monthly jump of 21.26% and a quarterly performance of 16.91%, while its annual performance rate touched 8.54%. The volatility ratio for the week stands at 2.87% while the volatility levels for the past 30 days are set at 3.63% for Cigna Corporation. The simple moving average for the period of the last 20 days is 0.74% for CI stocks with a simple moving average of 15.24% for the last 200 days.

Analysts’ Opinion of CI

Many brokerage firms have already submitted their reports for CI stocks, with SVB Leerink repeating the rating for CI by listing it as a “Mkt Perform.” The predicted price for CI in the upcoming period, according to SVB Leerink is $220 based on the research report published on July 01st of the current year 2020.

Bernstein, on the other hand, stated in their research note that they expect to see CI reach a price target of $223. The rating they have provided for CI stocks is “Mkt Perform” according to the report published on May 04th, 2020.


My Next COVID-19 Stock Alert Poised For Triple Digit Moves


Get Ready for my next COVID-19 stock idea.
I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.

 
 

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer

Sponsored


CI Trading at 13.29% from the 50-Day Moving Average

After a stumble in the market that brought CI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.76% of loss for the given period.

Volatility was left at 3.63%, however, over the last 30 days, the volatility rate increased by 2.87%, as shares surge +15.30% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +31.08% upper at present.

During the last 5 trading sessions, CI rose by +0.95%, which changed the moving average for the period of 200-days by -4.26% in comparison to the 20-day moving average, which settled at $211.87. In addition, Cigna Corporation saw 3.68% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CI starting from Sadler Jason D, who sale 6,000 shares at the price of $220.00 back on Nov 10. After this action, Sadler Jason D now owns 27,482 shares of Cigna Corporation, valued at $1,320,000 using the latest closing price.

Cordani David, the President & CEO of Cigna Corporation, sale 52,455 shares at $220.00 during a trade that took place back on Nov 10, which means that Cordani David is holding 253,427 shares at $11,540,100 based on the most recent closing price.

Stock Fundamentals for CI

Current profitability levels for the company are sitting at:

  • +5.90 for the present operating margin

The net margin for Cigna Corporation stands at +3.32. The total capital return value is set at 10.90, while invested capital returns managed to touch 6.47. Equity return is now at value 11.40, with 3.40 for asset returns.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Based on Cigna Corporation (CI), the company’s capital structure generated 82.51 points at debt to equity in total, while total debt to capital is 45.21. Total debt to assets is 24.62, with long-term debt to equity ratio resting at 70.34. Finally, the long-term debt to capital ratio is 38.54.

When we switch over and look at the enterrpise to sales, we see a ratio of 0.75, with the company’s debt to enterprise value settled at 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.74.

Previous Post

Physicians And Other Health Practitioners To Get Priority On UK’s COVID-19 Vaccine Distribution

Next Post

SUO 2020: Young Urulogic Oncologists: Top Poster Presentations

Next Post
SUO 2020: Young Urulogic Oncologists: Top Poster Presentations

SUO 2020: Young Urulogic Oncologists: Top Poster Presentations

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com